Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/187063
Title: Risk Factors and Outcomes of Acute Graft Pyelonephritis with Bacteremia Due to Multidrug-Resistant Gram-Negative Bacilli among Kidney Transplant Recipients
Author: Sabé Fernández, Nuria
Maristany Bosch, Marta
Tuells, Manel
Favà Buch, Alexandre
Melilli, Edoardo
Tubau, Fe
Cruzado, Josep Ma.
Carratalà, Jordi
Keywords: Trasplantament renal
Infeccions del tracte urinari
Kidney transplantation
Urinary tract infections
Issue Date: 2-Jun-2022
Publisher: MDPI
Abstract: Acute graft pyelonephritis (AGP) is the leading cause of bloodstream infection in kidney transplant (KT) recipients. The prevalence of urinary tract infections caused by multidrug-resistant (MDR) Gram-negative bacilli is increasing. This 14-year prospective observational study sought to determine the clinical characteristics, risk factors, and outcomes of AGP with bacteremia due to MDR Gram-negative bacilli. Overall, 278 episodes of AGP with bacteremia due to MDR Gram-negative and non-MDR Gram-negative bacilli were identified and compared in 214 KT recipients; MDR Gram-negative bacilli were the cause in 28.4%. Overall 30-day mortality was low (1.1%). Risk factors independently associated with AGP due to MDR Gram-negative bacilli were male sex (OR 3.08; 95%CI 1.60-5.93), previous episode of bacteremic AGP (OR 2.11, 95%CI 1.09-4.09), prior antibiotic therapy in the preceding month (OR 2.47, 95%CI 1.33-4.57), and nosocomial acquisition (OR 2.03, 95%CI 1.14-3.62). Forty-three percent of MDR Gram-negative episodes received inappropriate empirical antibiotic therapy. The risk factors identified in this study may help physicians when selecting empirical antibiotic treatment for AGP. Previous antibiotic use was the main modifiable factor. Its presence highlights the importance of avoiding unnecessary antibiotics in order to bring down the high rates of MDR Gram-negative bacilli infections in this population.
Note: Reproducció del document publicat a: https://doi.org/10.3390/jcm11113165
It is part of: Journal of Clinical Medicine, 2022, vol. 11, num. 11
URI: http://hdl.handle.net/2445/187063
Related resource: https://doi.org/10.3390/jcm11113165
ISSN: 2077-0383
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
jcm-11-03165.pdf291.59 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons